AI Article Synopsis
- The World Health Organization estimates that 5-10 million people are infected with HTLV-1, but this number could be low due to limited data.
- Reliable data exists for only about 1.5 billion people worldwide, leaving many infections potentially undetected.
- The study evaluates a new rapid test, Espline HTLV-I/II, which could enhance our ability to quickly and easily identify HTLV-1 infections without needing expensive lab equipment.
Article Abstract
The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data are available for only approximately 1.5 billion people worldwide. The point-of-care test is a powerful tool for the easy and quick detection of infections without the requirement for expensive instruments and laboratory equipment. Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test that was evaluated in this study, might significantly advance our understanding of the global epidemiology of HTLV-1 infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715220 | PMC |
| http://dx.doi.org/10.1128/spectrum.02078-23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!